scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0028-3908(97)00042-7 |
P698 | PubMed publication ID | 9225285 |
P2093 | author name string | Kennett GA | |
Blackburn TP | |||
Fone KC | |||
Lightowler S | |||
Duxon MS | |||
P2860 | cites work | Immunocytochemical localization and description of neurons expressing serotonin2 receptors in the rat brain | Q42505808 |
Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists | Q43621839 | ||
Axon-sparing lesions of the medial nucleus of the amygdala decrease affiliative behaviors in the prairie vole (Microtus ochrogaster): behavioral and anatomical specificity | Q48117665 | ||
Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors | Q48149092 | ||
Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination | Q48256994 | ||
5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze | Q48634831 | ||
Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus. | Q51171045 | ||
Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study. | Q51171870 | ||
The mouse 5-HT2B receptor: homologous subtype or species variant? | Q60696624 | ||
A simple and reliable conflict procedure for testing anti-anxiety agents | Q70564912 | ||
Mating and agonistic behavior produce different patterns of Fos immunolabeling in the male Syrian hamster brain | Q71980795 | ||
5-Hydroxytryptamine2a, 5-hydroxytryptamine2B, and 5-hydroxytryptamine2C receptor mRNA expression in the spinal cord of rat, cat, monkey and human | Q72110352 | ||
Functional evidence for a 5‐HT2B receptor mediating contraction of longitudinal muscle in human small intestine | Q24317175 | ||
Further characterization of 5-hydroxytryptamine receptors (putative 5-HT2B) in rat stomach fundus longitudinal muscle | Q24679434 | ||
Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety | Q24679647 | ||
Cloning and functional characterization of the human 5-HT2B serotonin receptor | Q28251302 | ||
Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists | Q28278816 | ||
5-HT2 receptor subtypes: a family re-united? | Q28303964 | ||
Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system | Q28583455 | ||
5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model | Q34243207 | ||
Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat. | Q34321873 | ||
In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist | Q34322537 | ||
Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects. | Q34327187 | ||
Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera. | Q34395395 | ||
Can social interaction be used to measure anxiety? | Q35177016 | ||
Serotonin and anxiety revisited | Q39625402 | ||
The contribution of the amygdala to normal and abnormal emotional states | Q40490212 | ||
Role of the amygdala and periaqueductal gray in anxiety and panic | Q40729187 | ||
Novel discriminatory ligands for 5-HT2B receptors. | Q41097250 | ||
Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans | Q41505588 | ||
Mediation by 5-hydroxytryptamine2B receptors of endothelium-dependent relaxation in rat jugular vein | Q42130226 | ||
P433 | issue | 4-5 | |
P921 | main subject | social interaction | Q609298 |
P1104 | number of pages | 8 | |
P304 | page(s) | 601-608 | |
P577 | publication date | 1997-04-01 | |
P1433 | published in | Neuropharmacology | Q15332439 |
P1476 | title | Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat. | |
P478 | volume | 36 |
Q51073688 | (+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats. |
Q38037141 | 5-HT2 ligands in the treatment of anxiety and depression |
Q28568610 | 5-Hydroxytryptamine2B receptors stimulate Ca2+ increases in cultured astrocytes from three different brain regions |
Q35071475 | A review of 25 years of the social interaction test |
Q28142963 | A review of central 5-HT receptors and their function |
Q24619584 | Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study |
Q43913142 | Alteration in 5-hydroxytryptamine agonist-induced behaviour following a corticosterone implant in adult rats |
Q28293653 | Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated |
Q44423335 | Blockade of serotonin 5-HT 1B and 5-HT 2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes |
Q51418969 | Chronic modulation of the GABA(A) receptor complex regulates Y1 receptor gene expression in the medial amygdala of transgenic mice. |
Q24309173 | Depletion of serotonin and selective inhibition of 2B receptor suppressed tumor angiogenesis by inhibiting endothelial nitric oxide synthase and extracellular signal-regulated kinase 1/2 phosphorylation |
Q48443500 | Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats |
Q52177592 | Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis. |
Q48313857 | Effect of combined administration of afobazole and 5-HT2b/2c receptor antagonist SB-200646A on neurochemical profile of brain structures in C57Bl/6 and BALB/c mice |
Q43670035 | Effect of repeated methylphenidate administration on presynaptic dopamine and behaviour in young adult rats |
Q51075764 | Effects of baseline anxiety on response to kindling of the right medial amygdala. |
Q33540480 | Effects of centrally administered anxiolytic compounds in animal models of anxiety |
Q36989910 | Emerging anxiolytics |
Q73665661 | Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat |
Q24680030 | Evidence that activation of central 5-HT(2B) receptors causes renal sympathoexcitation in anaesthetized rats |
Q43626712 | Expression of serotonin receptors in bone |
Q46402539 | Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation |
Q38354554 | Functional study of rat 5‐HT2A receptors using antisense oligonucleotides |
Q30501693 | Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning and expression |
Q41831449 | In vivo modulation of vagal-identified dorsal medullary neurones by activation of different 5-Hydroxytryptamine(2) receptors in rats |
Q45245210 | Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: a potential role for sodium channels? |
Q38632454 | Marine Inspired 2-(5-Halo-1H-indol-3-yl)-N,N-dimethylethanamines as Modulators of Serotonin Receptors: An Example Illustrating the Power of Bromine as Part of the Uniquely Marine Chemical Space |
Q30452399 | Melanocortin-4 receptor in the medial amygdala regulates emotional stress-induced anxiety-like behaviour, anorexia and corticosterone secretion |
Q33828072 | Modulation of ethanol withdrawal-induced anxiety-like behavior during later withdrawals by treatment of early withdrawals with benzodiazepine/gamma-aminobutyric acid ligands |
Q35001313 | Molecular targets in the treatment of anxiety |
Q28206145 | Molecular, pharmacological and functional diversity of 5-HT receptors |
Q30439434 | Neuronal localization of the 5-HT2 receptor family in the amygdaloid complex |
Q28564481 | Nicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: effects of the cannabinoid receptor 1 antagonist AM251 |
Q34172684 | Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. |
Q34432766 | SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist |
Q33856044 | SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats |
Q52332824 | Serotonergic Dysfunction in Amyotrophic Lateral Sclerosis and Parkinson's Disease: Similar Mechanisms, Dissimilar Outcomes. |
Q38089644 | Serotonergic innervation of the amygdala: targets, receptors, and implications for stress and anxiety |
Q27006485 | Signal Transduction in Astrocytes during Chronic or Acute Treatment with Drugs (SSRIs, Antibipolar Drugs, GABA-ergic Drugs, and Benzodiazepines) Ameliorating Mood Disorders |
Q40047762 | Social behavior in deer mice as a novel interactive paradigm of relevance for obsessive-compulsive disorder (OCD). |
Q35071483 | The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoamines |
Q37003432 | The melanocortinergic pathway is rapidly recruited by emotional stress and contributes to stress-induced anorexia and anxiety-like behavior |
Q35202929 | The neurobiology and control of anxious states |
Q44472607 | m-CPP-induced self-grooming is mediated by 5-HT2C receptors |
Search more.